{"schema_version":"1","generated_at":"2026-11-08T18:29:50.190Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jeffrey-patton","json_url":"https://www.findmykol.com/kol/jeffrey-patton/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jeffrey-patton","name":"Jeffrey Patton","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Tennessee Oncology","institution_url":"https://www.findmykol.com/institution/tennessee-oncology","city":"Nashville","state":"TN","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1801820519","openalex":"A5109930508"},"summary":"Jeffrey Patton is an Oncology physician affiliated with Tennessee Oncology. OpenAlex indexes 43 publications with 707 citations (h-index 12); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":43,"cited_by_count":707,"h_index":12,"latest_activity_year":2024,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00877045","title":"Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting","status":"COMPLETED","role":"Overall official","sponsor":"SCRI Development Innovations, LLC","source_url":"https://clinicaltrials.gov/study/NCT00877045","trial_url":"https://www.findmykol.com/trial/NCT00877045"},{"nct":"NCT00876382","title":"Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma","status":"COMPLETED","role":"Overall official","sponsor":"SCRI Development Innovations, LLC","source_url":"https://clinicaltrials.gov/study/NCT00876382","trial_url":"https://www.findmykol.com/trial/NCT00876382"},{"nct":"NCT00876070","title":"Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer","status":"COMPLETED","role":"Overall official","sponsor":"SCRI Development Innovations, LLC","source_url":"https://clinicaltrials.gov/study/NCT00876070","trial_url":"https://www.findmykol.com/trial/NCT00876070"}],"source":"trials"},"payments":{"company_count":12,"program_years":{"first":2021,"last":null},"rows_total":19,"shown":3,"withheld":16,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":122500,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801820519"},{"payer":"Karyopharm Therapeutics Inc.","program_year":2024,"amount_usd":4890,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801820519"},{"payer":"PUMA BIOTECHNOLOGY, INC.","program_year":2024,"amount_usd":2600,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801820519"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1801820519","source":"payments"},"similar":[{"name":"Ian Flinn","slug":"ian-flinn","institution":"Tennessee Oncology","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/ian-flinn","json_url":"https://www.findmykol.com/kol/ian-flinn/profile.json"},{"name":"Kent Shih","slug":"kent-shih","institution":"Tennessee Oncology","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/kent-shih","json_url":"https://www.findmykol.com/kol/kent-shih/profile.json"},{"name":"Gina Vaccaro","slug":"gina-vaccaro","institution":"Tennessee Oncology","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gina-vaccaro","json_url":"https://www.findmykol.com/kol/gina-vaccaro/profile.json"},{"name":"Wade Iams","slug":"wade-iams","institution":"Tennessee Oncology","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/wade-iams","json_url":"https://www.findmykol.com/kol/wade-iams/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":16}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}